-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
U.S. Stem Cell, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2022.
- U.S. Stem Cell, Inc. Operating Income (Loss) for the quarter ending December 31, 2022 was -$374K, a 3.19% decline year-over-year.
- U.S. Stem Cell, Inc. Operating Income (Loss) for the twelve months ending December 31, 2022 was -$1.72M, a 19.4% increase year-over-year.
- U.S. Stem Cell, Inc. annual Operating Income (Loss) for 2022 was -$1.72M, a 19.4% increase from 2021.
- U.S. Stem Cell, Inc. annual Operating Income (Loss) for 2021 was -$2.14M, a 11% increase from 2020.
- U.S. Stem Cell, Inc. annual Operating Income (Loss) for 2020 was -$2.4M, a 29.8% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)